Treatment of pulmonary hypertension with bombesin antagonist

Acoustic pressure wave orientation determination using structured light.

Optics express·2026

Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale.

Neuromuscular disorders : NMD·2026

Mortality of symptomatic children with spinal muscular atrophy in the era of disease-modifying therapies.

Neuromuscular disorders : NMD·2025

Epidemiology and diagnostic testing for hemochromatosis and iron overload.

International journal of laboratory hematology·2015

RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine.

Neuromuscular disorders : NMD·2014

Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients.

Neuromuscular disorders : NMD·2014

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Sex differences in alcohol and amphetamine-like compound consumption and their relationship with mu opioid receptor density in the pallidal-mesolimbic system.

Pharmacology, biochemistry, and behavior·2026

Ayahuasca treatment reduces 50-kHz ultrasonic vocalizations and modifies mesocorticolimbic monoamine neurochemistry in rats.

Pharmacology, biochemistry, and behavior·2026

Systematic identification of p11 as a signaling modulator across the GPCRome.

Science advances·2026

Paraventricular Hypothalamic GLP-1R Neurons Mediate Propofol-Induced Suppression of Food Intake.

Journal of integrative neuroscience·2026

Anxiolytic and antidepressant effects of 1-phenyl-1-propanol-mediated bile acids in a chronic unpredictable mild stress mouse model.

International immunopharmacology·2026

Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effective.

Nature communications·2026

Related Experiment Videos

Treatment of pulmonary hypertension with bombesin antagonist

Related Concept Videos

Acoustic pressure wave orientation determination using structured light.

Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale.

Mortality of symptomatic children with spinal muscular atrophy in the era of disease-modifying therapies.

Epidemiology and diagnostic testing for hemochromatosis and iron overload.

RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine.

Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Sex differences in alcohol and amphetamine-like compound consumption and their relationship with mu opioid receptor density in the pallidal-mesolimbic system.

Ayahuasca treatment reduces 50-kHz ultrasonic vocalizations and modifies mesocorticolimbic monoamine neurochemistry in rats.

Systematic identification of p11 as a signaling modulator across the GPCRome.

Paraventricular Hypothalamic GLP-1R Neurons Mediate Propofol-Induced Suppression of Food Intake.

Anxiolytic and antidepressant effects of 1-phenyl-1-propanol-mediated bile acids in a chronic unpredictable mild stress mouse model.

Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effective.

Related Experiment Videos

Treatment of pulmonary hypertension with bombesin antagonist

Related Concept Videos

Related Articles